对决:在家中远程医疗保养癌症护理有效且安全尺寸:务实的群集随机试验
Many people with cancer spend a lot of time and money traveling to and from the doctor's office for cancer care. MSK's goal is to make getting cancer care easier by cutting down the need to make in-person visits to MSK. MSK is trying to do this through a new option called enhanced telehealth.
研究概览
研究类型
注册 (估计的)
阶段
- 不适用
联系人和位置
学习联系方式
- 姓名:Erin Bange, MD, MSCE
- 电话号码:646-422-4680
- 邮箱:bangee@mskcc.org
研究联系人备份
- 姓名:Deborah Schrag, MD, MPH
- 电话号码:212-639-5851
学习地点
-
-
New Jersey
-
Basking Ridge、New Jersey、美国、07920
- 招聘中
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities)
-
接触:
- Erin Bange, MD, MSCE
- 电话号码:646-422-4680
-
Middletown、New Jersey、美国、07748
- 招聘中
- Memorial Sloan Kettering Monmouth (All Protocol Activities)
-
接触:
- Erin Bange, MD, MSCE
- 电话号码:646-422-4680
-
Montvale、New Jersey、美国、07645
- 招聘中
- Memorial Sloan Kettering Bergen (All Protocol Activities)
-
接触:
- Erin Bange, MD, MSCE
- 电话号码:646-422-4680
-
-
New York
-
Commack、New York、美国、11725
- 招聘中
- Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities)
-
接触:
- Erin Bange, MD, MSCE
- 电话号码:646-422-4680
-
Harrison、New York、美国、10604
- 招聘中
- Memorial Sloan Kettering Westchester (All Protocol Activities)
-
接触:
- Erin Bange, MD, MSCE
- 电话号码:646-422-4680
-
New York、New York、美国、10065
- 招聘中
- Memorial Sloan Kettering Cancer Center (All Protocol Activites)
-
接触:
- Erin Bange, MD, MSCE
- 电话号码:646-422-4680
-
Uniondale、New York、美国、11553
- 招聘中
- Memorial Sloan Kettering Nassau (All Protocol Activities)
-
接触:
- Erin Bange, MD, MSCE
- 电话号码:646-422-4680
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Patients with breast or prostate cancer at Memorial Sloan Kettering Cancer Center who have had at least 3 prior medical oncology visits.
Exclusion Criteria:
- Patient is enrolled on a therapeutic clinical trial.
- Patients whose primary language is not currently supported by Epic.
学习计划
研究是如何设计的?
设计细节
- 主要用途:卫生服务研究
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
有源比较器:Usual practice pattern (UPP)
Usual practice pattern (UPP) of patient's medical oncologist |
Patient follows usual practice pattern for routine care Patient follows enhanced telehealth practice pattern. As clinically appropriate, patients given option to shift routine care from face-to-face to at-home services available at institution: telehealth visits, home phlebotomy, and educational support for home administration of injection medications |
|
实验性的:Enhanced Telehealth (ET)
Enhanced Telehealth (ET) practice pattern of patient's medical oncologist |
Patient follows usual practice pattern for routine care Patient follows enhanced telehealth practice pattern. As clinically appropriate, patients given option to shift routine care from face-to-face to at-home services available at institution: telehealth visits, home phlebotomy, and educational support for home administration of injection medications |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Proportion of routine face to face medical oncology related visits out of total medical oncology related visits
大体时间:12 months
|
all patients who meet eligibility criteria and have completed at least 2 medical oncology visits during the 12 month follow up period will be included for endpoint evaluability during analyses |
12 months
|
合作者和调查者
调查人员
- 首席研究员:Erin Bange, MD, MSCE、Memorial Sloan Kettering Cancer Center
出版物和有用的链接
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他相关的 MeSH 术语
其他研究编号
- 25-055
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
IPD 计划说明
Memorial Sloan Kettering Cancer Center supports the international committee of medical journal editors (ICMJE) and the ethical obligation of responsible sharing of data from clinical trials. The protocol summary, a statistical summary, and informed consent form will be made available on clinicaltrials.gov when required as a condition of Federal awards, other agreements supporting the research and/or as otherwise required. Requests for deidentified individual participant data can be made beginning 12 months after publication and for up to 36 months post publication. Deidentified individual participant data reported in the manuscript will be shared under the terms of a Data Use Agreement and may only be used for approved proposals. Requests may be made to: crdatashare@mskcc.org.
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.